亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

In the literature: April 2017

医学 放射治疗 外科 结直肠癌 临床终点 随机对照试验 癌症 内科学
作者
Andrés Cervantes
出处
期刊:ESMO open [Elsevier BV]
卷期号:2 (2): e000193-e000193
标识
DOI:10.1136/esmoopen-2017-000193
摘要

The full publication in Lancet Oncology of the Stockholm III trial helps us to understand that short-course radiotherapy in patients with localised rectal cancer could also be followed by delayed surgery.1.Erlandsson J. Holm T. Pettersson D. et al.Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal Cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.Lancet Oncol. 2017; 18: 336-346doi:10.1016/S1470-2045(17)30086-4Abstract Full Text Full Text PDF PubMed Scopus (322) Google Scholar During more than 14 years, more than 800 patients with rectal cancer not showing unresectable features were randomised in a two-arm versus three-arm study with a non-inferiority design. Patients could be randomised to short-course radiotherapy (5×5 Gy) and immediate (within a week) versus delayed (4–8 weeks) surgery. In the three-arm randomisation patients could also be allocated to a long course of concurrent chemoradiation (25×2 Gy), with surgery performed 6–8 weeks thereafter. Time to local recurrence was established as the primary endpoint. Interestingly, short-course radiotherapy followed by delayed surgery was proven to have less acute toxicity and a lower postoperative complication rate compared with immediate surgery. Oncological results were similar among the three arms. The authors conclude that short-course radiotherapy with surgery delayed for 4–8 weeks might have certain advantages over immediate surgery in rectal cancer treatment. Another interesting fact observed in this study is that tumour regression and downstaging is seen in the delayed surgery arm, achieving a pathological complete response rate of 11.8%, while tumour regression is rarely appreciated in the immediate surgery group.2.Pettersson D. Lörinc E. Holm T. et al.Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer.Br J Surg. 2015; 102: 972-978doi:10.1002/bjs.9811Crossref PubMed Scopus (135) Google Scholar Moreover, delayed surgery allows the integration of chemotherapy after short-course radiation in patients with locally advanced tumours. This strategy has been further developed in the RAPIDO trial, which already completed accrual and whose results are to be reported in about 3 years from now. Uterine carcinosarcomas are uncommon malignancies involving 5% of all endometrial neoplasms. Mixed morphological features with epithelial and mesenchymal components characterise them. In general, they are treated in a way similar to high-grade serous endometrial or ovarian malignancies, but its molecular landscape was far from being known. A paper published in Cancer Cell by the Cancer Genome Atlas Research Network reveals the most common molecular alterations harboured by them.3.Cherniack A.D. Shen H. Walter V. et al.Integrated molecular characterization of Uterine Carcinosarcoma.Cancer Cell. 2017; 31: 411-423doi:10.1016/j.ccell.2017.02.010Abstract Full Text Full Text PDF PubMed Scopus (230) Google Scholar In a very comprehensive analysis, including genomic, epigenomic, transcriptomic and proteomic characterisations of a series of 57 uterine carcinosarcomas, the authors show extensive copy number alterations as well as a high frequency of mutations. The most relevant were found in TP53, PTEN, PIK3CA, PPP2R1A, FBXW7 and KRAS. This observation makes them very similar to high-grade serous tumours. Recurring focal amplifications include those containing the oncogenes TERC, FGFR3, MYC, KAT6A, MDM2, ERBB2, CCNE1 and BCL2L1. Recurring focal deletions contained the tumour suppressors PTPRD and RB1. These multiple molecular alterations may add some experimental therapeutic options, such as the use of PARP, EZH2, cell-cycle and PI3K pathway inhibitors. But perhaps the most striking feature found was the strong epithelial mesenchymal transition signature in the transcriptomic analysis. The significant association of epithelial mesenchymal transition scores extends to the expression of E-cadherin at the gene and protein levels, as well as to CDH1 regulators SNAI1/2 and ZEB1/2, which are direct miR-200 family targets. The expression of 131 genes identified as being correlated with epithelial mesenchymal transition was more strongly correlated with the epithelial mesenchymal transition scores in uterine carcinosarcoma than in other gynaecological cancers. All these findings are expected to contribute to the development of a more rational and personalised approach to the treatment of this uncommon uterine neoplasm. Better and more precise knowledge is needed to unveil the mechanisms of tumour progression and metastases in lung cancer. In this regard, investigators at Stanford University have recently published in Nature Medicine a series of elegant experiments showing the potential value of the Jak–Stat3 signalling axis as a potential therapeutic target in lung cancer.4.Chuang C.H. Greenside P.G. Rogers Z.N. et al.Molecular definition of a metastatic lung Cancer state reveals a targetable CD109-Janus kinase-Stat Axis.Nat Med. 2017; 23: 291-300doi:10.1038/nm.4285Crossref PubMed Scopus (95) Google Scholar To identify the potential driving actors behind metastatic dissemination, the genes enriched in metastases were compared with those obtained from non-metastatic primary tumours. The authors selected 23 of the most differentially expressed genes between metastatic and non-metastatic tumours for which prometastatic activity had not been described previously, and modulated their activity in a functional in vivo model. Interestingly, the knockdown of CD109, a glycoprotein expressed in the surface of T cells and activated platelets, as well as progenitor haematopoietic cells, was able to significantly reduce lung and liver metastases by more than 90% in those in vivo models. They also found that cells lacking CD109 have decreased clonal growth and migration when compared with wild-type cells, which suggests that CD109 plays a role in the initiation of the metastatic cascade. Gene expression profiling showed that CD109 knockdown blocks STAT3 signalling and JAk1 proved to be the main regulator of STAT3. A more detailed study of the CD109–JAk1–STAT3 axis could open a new way for the development of new targeted therapies, tackling the mechanisms that make metastatic disease to occur.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
tsuki完成签到,获得积分10
1秒前
科研通AI6.2的应助被Prof.Z采纳,获得10
14秒前
完美世界的应助被whc采纳,获得10
16秒前
18秒前
amiee发布了新的文献求助10
23秒前
jennica发布了新的文献求助30
29秒前
yc关闭了yc的文献求助
29秒前
33秒前
漂亮的新梅完成签到,获得积分10
34秒前
所所的应助被羊羊吃芋圆采纳,获得10
37秒前
whc发布了新的文献求助10
38秒前
48秒前
54秒前
辛勤诗兰完成签到,获得积分10
1分钟前
羊羊吃芋圆完成签到,获得积分10
1分钟前
情怀的应助被Prof.Z采纳,获得10
1分钟前
caicai完成签到,获得积分20
1分钟前
踏实的盼柳的应助被朝朝采纳,获得10
1分钟前
Jasper的应助被科研通管家采纳,获得10
1分钟前
1分钟前
hhz发布了新的文献求助10
1分钟前
科研通AI6.3的应助被skyboyxiaobobo采纳,获得10
1分钟前
幽森之魅完成签到,获得积分10
1分钟前
大模型的应助被whc采纳,获得10
1分钟前
优秀笑柳完成签到,获得积分10
1分钟前
任性星星完成签到 ,获得积分10
1分钟前
hhz完成签到,获得积分10
1分钟前
Linden_bd完成签到 ,获得积分0
2分钟前
2分钟前
2分钟前
molihuakai的应助被amiee采纳,获得10
2分钟前
2分钟前
2分钟前
林一发布了新的文献求助10
2分钟前
余香的应助被icey采纳,获得10
2分钟前
icey对应助文件撤销了驳回
3分钟前
3分钟前
林一完成签到,获得积分10
3分钟前
amiee发布了新的文献求助10
3分钟前
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190148
求助须知:如何正确求助?哪些是违规求助? 9577257
关于积分的说明 21852269
捐赠科研通 7788498
什么是DOI,文献DOI怎么找? 3436259
关于科研通互助平台的介绍 2560043
邀请新用户注册赠送积分活动 2482880